Skip to main content
驱动力 logo

驱动力 — Investor Relations & Filings

Ticker · 920275 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 479 across all filing types
Latest filing 2024-08-27 Governance Information
Country CN China
Listing Beijing Stock Exchange 920275

About 驱动力

https://www.chinaedrive.com/

Drive Power Bio-tech specializes in the research, development, and manufacturing of functional additives designed for animal nutrition. The company focuses on hematopoietic technology, providing solutions that enhance hemoglobin synthesis, strengthen immune responses, and support intestinal health. Its product portfolio includes specialized nutritional supplements that optimize metabolic processes and improve growth performance. By leveraging biotechnological innovation, the company develops high-efficiency additives aimed at enhancing physiological health and production efficiency in large-scale agricultural environments.

Recent filings

Filing Released Lang Actions
《董事会秘书工作制度》
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled '董事会秘书工作制度' (Board Secretary Work System) issued by the company's board on August 28, 2024. It outlines the duties, qualifications, appointment, and responsibilities of the board secretary. There are no financial statements, earnings data, or regulatory filings such as audit reports or annual reports. It is not an announcement of a report but a governance-related internal regulation. This fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2024-08-27 Chinese
华安证券股份有限公司关于广东驱动力生物科技股份有限公司募集资金投资项目延期的核查意见
Regulatory Filings Classification · 95% confidence The document is a formal opinion from a securities company acting as a sponsor regarding the delay in a fundraising investment project by Guangdong Drive Biological Technology Group Co., Ltd. It details the background of the fundraising, the use of funds, the reasons for the delay, and the approval process by the board and supervisory committee. The document references regulatory rules and approvals but does not contain financial statements or detailed financial results. It is a regulatory announcement about the status of a fundraising project and its delay, not a full financial report or earnings release. The document length is short (2081 characters), and it serves as a formal verification and announcement of the fundraising project delay. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2024-08-27 Chinese
2024年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2024 半年度募集资金存放与实际使用情况的专项报告" which translates to a "2024 Semi-Annual Special Report on the Deposit and Actual Use of Raised Funds." It details the use of funds raised from a stock issuance, including amounts raised, usage, management, and investment of idle funds. The document includes detailed financial figures and explanations about the use of proceeds from a capital raise, including compliance with regulatory requirements and internal controls. It is a specialized report focused on the use of capital raised, not a general financial report like an annual or interim report. This fits the category of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document length is over 6000 characters and contains substantive financial data related to fundraising usage, not just an announcement or certification. Therefore, the correct classification is CAP with high confidence.
2024-08-27 Chinese
《对外投资管理制度》
Governance Information Classification · 95% confidence The document is titled as an "Investment Management System" of Guangdong Driving Force Biotechnology Group Co., Ltd., detailing the company's internal policies and procedures for external investments. It includes governance, approval processes, responsibilities, and risk management related to investments. There is no financial data, earnings information, or audit results presented. The document is a formal policy or governance document issued by the board, not a financial report or announcement of voting results. It is not a report publication announcement since it contains substantive content rather than a brief notice. The content aligns with governance information about company internal rules and procedures regarding investments. Therefore, the most appropriate classification is Governance Information (CGR).
2024-08-27 Chinese
《内幕信息知情人管理制度》
Governance Information Classification · 95% confidence The document is a detailed internal regulation system regarding the management of insider information for Guangdong Driving Force Biotechnology Group Co., Ltd. It outlines procedures, responsibilities, and legal compliance related to insider information, including definitions, reporting requirements, confidentiality obligations, and penalties for violations. The document references regulatory frameworks and stock exchange rules but does not contain financial statements, earnings data, or direct financial results. It is a governance-related document focused on internal controls and compliance rather than a financial report or announcement. Therefore, it fits best under Governance Information (CGR). The document length (6853 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive governance policy document.
2024-08-27 Chinese
2024年半年度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "半年度报告" which translates to "Half-Year Report" or "Interim Report" for the period January 1, 2024 to June 30, 2024. It contains detailed financial data including income statement, balance sheet, cash flow analysis, business overview, risk factors, and management discussion. The length is substantial (15,000 characters), and it includes actual financial statements and analysis rather than just an announcement or certification. The content matches the definition of an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year with substantive financial data and analysis. Therefore, the correct classification is IR with high confidence. H1 2024
2024-08-27 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.